PYRIDOSTIGMINE BROMIDE

PYRIDOSTIGMINE BROMIDE was reported 7627 times

These side effects are most commonly reported by patients taking PYRIDOSTIGMINE BROMIDE:

# Side effect Count
0 MYASTHENIA GRAVIS 878
1 FATIGUE 781
2 DRUG INEFFECTIVE 635
3 ASTHENIA 614
4 OFF LABEL USE 598
5 DIARRHOEA 566
6 HEADACHE 537
7 DYSPNOEA 529
8 NAUSEA 480
9 MUSCULAR WEAKNESS 410
10 FALL 389
11 DIZZINESS 344
12 MALAISE 317
13 PAIN 310
14 DIPLOPIA 296
15 DYSPHAGIA 285
16 CONDITION AGGRAVATED 275
17 PRODUCT DOSE OMISSION ISSUE 268
18 VOMITING 265
19 ARTHRALGIA 250
20 PYREXIA 232
21 URINARY TRACT INFECTION 232
22 PNEUMONIA 230
23 PARAESTHESIA 223
24 GAIT DISTURBANCE 217
25 WEIGHT DECREASED 215
26 COVID-19 201
27 MUSCLE SPASMS 198
28 BLOOD PRESSURE INCREASED 196
29 DEATH 191
30 EYELID PTOSIS 190
31 FEELING ABNORMAL 190
32 PAIN IN EXTREMITY 186
33 ABDOMINAL PAIN UPPER 185
34 COUGH 185
35 RASH 179
36 BACK PAIN 178
37 MYASTHENIA GRAVIS CRISIS 173
38 WEIGHT INCREASED 172
39 INSOMNIA 163
40 INTENTIONAL PRODUCT USE ISSUE 158
41 SOMNOLENCE 145
42 HYPOAESTHESIA 141
43 HYPOTENSION 140
44 PRODUCT USE IN UNAPPROVED INDICATION 140
45 ANXIETY 139
46 NASOPHARYNGITIS 137
47 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 136
48 PRURITUS 136
49 ABDOMINAL PAIN 135
50 MYALGIA 133
51 ABDOMINAL DISCOMFORT 132
52 VISION BLURRED 131
53 DEPRESSION 129
54 HYPERTENSION 128
55 TREMOR 121
56 CHILLS 116
57 BALANCE DISORDER 113
58 DYSARTHRIA 111
59 HYPERHIDROSIS 111
60 SINUSITIS 109
61 SPEECH DISORDER 109
62 THERAPEUTIC RESPONSE SHORTENED 109
63 DECREASED APPETITE 108
64 HOSPITALISATION 108
65 INFECTION 108
66 PARAESTHESIA ORAL 105
67 CONSTIPATION 104
68 INFLUENZA 103
69 URTICARIA 101
70 PERIPHERAL SWELLING 99
71 VISUAL IMPAIRMENT 97
72 ANAEMIA 95
73 GASTROINTESTINAL DISORDER 95
74 RESPIRATORY FAILURE 94
75 INJECTION SITE PAIN 93
76 LOSS OF CONSCIOUSNESS 91
77 CONFUSIONAL STATE 90
78 DEHYDRATION 90
79 DRUG INTERACTION 90
80 MIGRAINE 89
81 ILLNESS 88
82 SEPSIS 86
83 CONTUSION 82
84 CHEST PAIN 81
85 MYASTHENIC SYNDROME 80
86 ERYTHEMA 78
87 MEMORY IMPAIRMENT 77
88 STRESS 76
89 HYPERSENSITIVITY 74
90 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 74
91 HALLUCINATION 73
92 DRUG INTOLERANCE 72
93 INFUSION RELATED REACTION 72
94 MUSCULOSKELETAL STIFFNESS 72
95 NECK PAIN 72
96 INCORRECT DOSE ADMINISTERED 71
97 INSURANCE ISSUE 71
98 NEUROPATHY PERIPHERAL 71
99 OXYGEN SATURATION DECREASED 71
100 SYNCOPE 71
101 MOBILITY DECREASED 70
102 PALPITATIONS 70
103 ATRIAL FIBRILLATION 69
104 CELLULITIS 69
105 DYSPNOEA EXERTIONAL 69
106 ARTHRITIS 68
107 DYSPHONIA 68
108 PRODUCT SUBSTITUTION ISSUE 68
109 PRODUCT USE ISSUE 67
110 HEART RATE INCREASED 66
111 SYMPTOM RECURRENCE 66
112 CHEST DISCOMFORT 65
113 RHINORRHOEA 64
114 BRONCHITIS 63
115 GENERAL PHYSICAL HEALTH DETERIORATION 63
116 THERAPY INTERRUPTED 63
117 BRADYCARDIA 62
118 SWELLING 61
119 DRUG HYPERSENSITIVITY 60
120 SEIZURE 60
121 ACUTE KIDNEY INJURY 59
122 CATARACT 59
123 COMA 59
124 DIABETES MELLITUS 59
125 HAEMOGLOBIN DECREASED 59
126 UNEVALUABLE EVENT 59
127 ALOPECIA 58
128 HERPES ZOSTER 58
129 BLOOD PRESSURE DECREASED 57
130 CHOKING 57
131 HEPATIC ENZYME INCREASED 57
132 JOINT SWELLING 57
133 SLEEP DISORDER 57
134 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 57
135 ABDOMINAL DISTENSION 56
136 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 56
137 THROMBOSIS 55
138 PULMONARY EMBOLISM 53
139 VIRAL INFECTION 53
140 BLOOD GLUCOSE INCREASED 52
141 UPPER RESPIRATORY TRACT INFECTION 52
142 FLUID RETENTION 51
143 OEDEMA PERIPHERAL 51
144 TACHYCARDIA 51
145 VERTIGO 51
146 BLOOD PRESSURE FLUCTUATION 50
147 LIMB DISCOMFORT 50
148 ILL-DEFINED DISORDER 49
149 INFLUENZA LIKE ILLNESS 49
150 ANAPHYLACTIC REACTION 48
151 CEREBROVASCULAR ACCIDENT 48
152 DYSSTASIA 48
153 HEAD INJURY 48
154 HYPOAESTHESIA ORAL 48
155 NEPHROLITHIASIS 48
156 PNEUMONIA ASPIRATION 48
157 THERAPEUTIC RESPONSE DECREASED 48
158 DEEP VEIN THROMBOSIS 47
159 NO ADVERSE EVENT 47
160 OEDEMA 47
161 OROPHARYNGEAL PAIN 47
162 GASTROOESOPHAGEAL REFLUX DISEASE 46
163 HYPOKALAEMIA 46
164 TREATMENT NONCOMPLIANCE 46
165 WHITE BLOOD CELL COUNT INCREASED 46
166 ASTHMA 44
167 CARDIAC DISORDER 44
168 LUNG DISORDER 44
169 MYOCARDIAL INFARCTION 44
170 PRODUCT QUALITY ISSUE 44
171 DIVERTICULITIS 43
172 DRY MOUTH 43
173 FLUSHING 43
174 THERAPEUTIC PRODUCT EFFECT DECREASED 43
175 OSTEOPOROSIS 42
176 THERAPY NON-RESPONDER 42
177 CARDIAC FAILURE 41
178 EAR INFECTION 41
179 INFLAMMATION 41
180 LETHARGY 41
181 NASAL CONGESTION 41
182 SWELLING FACE 41
183 THERAPY CESSATION 41
184 EYE DISORDER 40
185 MEDICATION ERROR 40
186 ADVERSE DRUG REACTION 39
187 DYSPEPSIA 38
188 LEUKOPENIA 38
189 MENINGITIS ASEPTIC 38
190 OVERDOSE 38
191 RESPIRATORY DISORDER 38
192 RESPIRATORY DISTRESS 38
193 SALIVARY HYPERSECRETION 38
194 THROAT TIGHTNESS 38
195 WHITE BLOOD CELL COUNT DECREASED 38
196 WRONG PATIENT RECEIVED PRODUCT 38
197 BLOOD PRESSURE SYSTOLIC INCREASED 37
198 DEVICE ISSUE 37
199 DISEASE PROGRESSION 37
200 FEELING COLD 37
201 GAIT INABILITY 37
202 RESPIRATORY TRACT INFECTION 37
203 THROAT IRRITATION 37
204 ADVERSE EVENT 36
205 EPISTAXIS 36
206 MASTICATION DISORDER 36
207 MUSCLE TWITCHING 36
208 PRODUCTIVE COUGH 36
209 URINARY INCONTINENCE 36
210 CARDIAC ARREST 35
211 INJECTION SITE BRUISING 35
212 POOR VENOUS ACCESS 35
213 SURGERY 35
214 AGITATION 34
215 DEPRESSED MOOD 34
216 GASTROINTESTINAL HAEMORRHAGE 34
217 SLEEP APNOEA SYNDROME 34
218 APHASIA 33
219 BONE PAIN 33
220 FUNGAL INFECTION 33
221 LIP SWELLING 33
222 PHARMACEUTICAL PRODUCT COMPLAINT 33
223 RHEUMATOID ARTHRITIS 33
224 THERAPEUTIC RESPONSE UNEXPECTED 33
225 THROMBOCYTOPENIA 33
226 URINARY RETENTION 33
227 COGNITIVE DISORDER 32
228 DRUG EFFECT LESS THAN EXPECTED 32
229 FEELING HOT 32
230 HEART RATE DECREASED 32
231 BLOOD POTASSIUM DECREASED 31
232 HOT FLUSH 31
233 PANCYTOPENIA 31
234 PSYCHOTIC DISORDER 31
235 RENAL FAILURE 31
236 BRAIN FOG 30
237 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 30
238 CYSTITIS 30
239 HYPERKALAEMIA 30
240 THYMOMA 30
241 AGGRESSION 29
242 ASPARTATE AMINOTRANSFERASE INCREASED 29
243 C-REACTIVE PROTEIN INCREASED 29
244 HYPERSOMNIA 29
245 IRRITABILITY 29
246 PERIPHERAL COLDNESS 29
247 PULMONARY MASS 29
248 RECTAL HAEMORRHAGE 29
249 RIB FRACTURE 29
250 ALANINE AMINOTRANSFERASE INCREASED 28
251 CARDIO-RESPIRATORY ARREST 28
252 DISCOMFORT 28
253 HAEMATOMA 28
254 INJECTION SITE ERYTHEMA 28
255 LIMB INJURY 28
256 MOVEMENT DISORDER 28
257 PHOTOPHOBIA 28
258 PLEURAL EFFUSION 28
259 POLLAKIURIA 28
260 POOR QUALITY SLEEP 28
261 TOXICITY TO VARIOUS AGENTS 28
262 UNRESPONSIVE TO STIMULI 28
263 BURNING SENSATION 27
264 IMMUNOSUPPRESSION 27
265 MUSCULOSKELETAL PAIN 27
266 PRESCRIBED OVERDOSE 27
267 STAPHYLOCOCCAL INFECTION 27
268 EYE PAIN 26
269 LACRIMATION INCREASED 26
270 LEUKOCYTOSIS 26
271 NEEDLE ISSUE 26
272 PRODUCT PHYSICAL ISSUE 26
273 RESPIRATORY ARREST 26
274 AMNESIA 25
275 DYSURIA 25
276 EMOTIONAL DISTRESS 25
277 HYPOXIA 25
278 PANCREATITIS 25
279 PRODUCT AVAILABILITY ISSUE 25
280 SENSORY DISTURBANCE 25
281 BLOOD IRON DECREASED 24
282 BONE DISORDER 24
283 DRUG DOSE OMISSION 24
284 HYPONATRAEMIA 24
285 INJECTION SITE SWELLING 24
286 INTENTIONAL DOSE OMISSION 24
287 LOCALISED INFECTION 24
288 SEASONAL ALLERGY 24
289 DYSGEUSIA 23
290 GASTROENTERITIS 23
291 HAEMATURIA 23
292 INFUSION SITE PAIN 23
293 MUSCLE FATIGUE 23
294 NERVOUSNESS 23
295 PLATELET COUNT DECREASED 23
296 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 23
297 PRODUCT RESIDUE PRESENT 23
298 RED BLOOD CELL COUNT DECREASED 23
299 ROAD TRAFFIC ACCIDENT 23
300 THERAPY CHANGE 23
301 TRANSIENT ISCHAEMIC ATTACK 23
302 ACUTE RESPIRATORY FAILURE 22
303 BACTERIAL INFECTION 22
304 BLOOD PRESSURE ABNORMAL 22
305 COLD SWEAT 22
306 DELIRIUM 22
307 DISTURBANCE IN ATTENTION 22
308 DRY EYE 22
309 DYSKINESIA 22
310 GAMMA-GLUTAMYLTRANSFERASE INCREASED 22
311 GASTROENTERITIS VIRAL 22
312 HAEMORRHAGE 22
313 HYPERGLYCAEMIA 22
314 INJECTION SITE PRURITUS 22
315 MEDICATION RESIDUE PRESENT 22
316 NIGHT SWEATS 22
317 PROCEDURAL PAIN 22
318 SKIN LACERATION 22
319 WOUND 22
320 ANGER 21
321 ARRHYTHMIA 21
322 BLEPHAROSPASM 21
323 BLOOD CREATININE INCREASED 21
324 BURSITIS 21
325 CHOLINERGIC SYNDROME 21
326 CLOSTRIDIUM DIFFICILE INFECTION 21
327 DERMATITIS CONTACT 21
328 DRUG DEPENDENCE 21
329 FLATULENCE 21
330 GLYCOSYLATED HAEMOGLOBIN INCREASED 21
331 INTENTIONAL PRODUCT MISUSE 21
332 INTERVERTEBRAL DISC PROTRUSION 21
333 JOINT STIFFNESS 21
334 MUSCULOSKELETAL DISCOMFORT 21
335 NEURALGIA 21
336 PANIC ATTACK 21
337 PRESYNCOPE 21
338 RENAL IMPAIRMENT 21
339 UPPER LIMB FRACTURE 21
340 WALKING AID USER 21
341 WHEEZING 21
342 AUTOIMMUNE DISORDER 20
343 DECREASED ACTIVITY 20
344 DISEASE RECURRENCE 20
345 DISORIENTATION 20
346 DRUG ABUSE 20
347 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 20
348 EATING DISORDER 20
349 GLAUCOMA 20
350 HAEMATOCRIT DECREASED 20
351 HIP FRACTURE 20
352 HYPOGLYCAEMIA 20
353 PARKINSON^S DISEASE 20
354 PRODUCT DISTRIBUTION ISSUE 20
355 PRODUCT DOSE OMISSION 20
356 SKIN ULCER 20
357 THERMAL BURN 20
358 ASPIRATION 19
359 BLINDNESS 19
360 BLOOD CREATINE PHOSPHOKINASE INCREASED 19
361 CHOLELITHIASIS 19
362 DRUG EFFECT DECREASED 19
363 EYE IRRITATION 19
364 HAEMATOCHEZIA 19
365 INFUSION SITE ERYTHEMA 19
366 LACTIC ACIDOSIS 19
367 LIVER DISORDER 19
368 MICTURITION URGENCY 19
369 MUSCLE CONTRACTIONS INVOLUNTARY 19
370 ORAL HERPES 19
371 PRODUCT DOSE OMISSION IN ERROR 19
372 SYRINGE ISSUE 19
373 TREATMENT FAILURE 19
374 UNDERDOSE 19
375 AGRANULOCYTOSIS 18
376 ATELECTASIS 18
377 BLOOD PRESSURE DIASTOLIC DECREASED 18
378 CONJUNCTIVITIS 18
379 HEART RATE IRREGULAR 18
380 HYPOACUSIS 18
381 INFUSION SITE EXTRAVASATION 18
382 INJECTION SITE REACTION 18
383 MUSCULOSKELETAL CHEST PAIN 18
384 NEOPLASM MALIGNANT 18
385 NEUTROPHIL COUNT INCREASED 18
386 PHARYNGEAL SWELLING 18
387 SECRETION DISCHARGE 18
388 SEPTIC SHOCK 18
389 SYSTEMIC LUPUS ERYTHEMATOSUS 18
390 THINKING ABNORMAL 18
391 ACUTE MYOCARDIAL INFARCTION 17
392 ARTHROPATHY 17
393 CYST 17
394 DEPRESSED LEVEL OF CONSCIOUSNESS 17
395 DROOLING 17
396 ECZEMA 17
397 EXPOSURE DURING PREGNANCY 17
398 FACIAL PAIN 17
399 FEELING JITTERY 17
400 FEMUR FRACTURE 17
401 FIBROMYALGIA 17
402 FOOT FRACTURE 17
403 GASTRITIS 17
404 HERNIA 17
405 HYPOPHAGIA 17
406 IMMUNODEFICIENCY 17
407 INCONTINENCE 17
408 INFUSION SITE HAEMORRHAGE 17
409 MENINGITIS 17
410 MULTIPLE SCLEROSIS RELAPSE 17
411 MUSCLE ATROPHY 17
412 OCULAR MYASTHENIA 17
413 ORTHOSTATIC HYPOTENSION 17
414 OSTEOARTHRITIS 17
415 PRE-EXISTING CONDITION IMPROVED 17
416 PRODUCT ADMINISTRATION INTERRUPTED 17
417 SKIN LESION 17
418 UROSEPSIS 17
419 APHONIA 16
420 APNOEA 16
421 BLOOD URINE PRESENT 16
422 DELUSION 16
423 DRUG EXPOSURE DURING PREGNANCY 16
424 DRY SKIN 16
425 ESCHERICHIA URINARY TRACT INFECTION 16
426 FEBRILE NEUTROPENIA 16
427 GASTRIC ULCER 16
428 IMPAIRED GASTRIC EMPTYING 16
429 INJECTION SITE HAEMORRHAGE 16
430 INJURY 16
431 LOWER RESPIRATORY TRACT INFECTION 16
432 LYMPHADENOPATHY 16
433 MATERNAL EXPOSURE DURING PREGNANCY 16
434 OPHTHALMOPLEGIA 16
435 PROCEDURAL HEADACHE 16
436 PRODUCT ADMINISTRATION ERROR 16
437 RASH PRURITIC 16
438 SHOCK 16
439 SKIN INFECTION 16
440 SKIN IRRITATION 16
441 WRIST FRACTURE 16
442 BACK INJURY 15
443 BLOOD UREA INCREASED 15
444 CARDIAC FAILURE CONGESTIVE 15
445 CONVULSION 15
446 DEMENTIA 15
447 DIZZINESS POSTURAL 15
448 EAR PAIN 15
449 GASTRIC INFECTION 15
450 HAEMORRHOIDS 15
451 HEREDITARY ANGIOEDEMA 15
452 HYPOTHYROIDISM 15
453 INFUSION SITE DISCHARGE 15
454 INTESTINAL OBSTRUCTION 15
455 KNEE ARTHROPLASTY 15
456 NEOPLASM PROGRESSION 15
457 NEUTROPENIA 15
458 PARALYSIS 15
459 PLASMAPHERESIS 15
460 PSORIASIS 15
461 RENAL DISORDER 15
462 SCIATICA 15
463 SPINAL PAIN 15
464 STRABISMUS 15
465 SUICIDAL IDEATION 15
466 SWOLLEN TONGUE 15
467 TEMPERATURE INTOLERANCE 15
468 THERAPEUTIC RESPONSE DELAYED 15
469 URINE OUTPUT DECREASED 15
470 VITAMIN D DEFICIENCY 15
471 ABORTION SPONTANEOUS 14
472 ANAL INCONTINENCE 14
473 ASTHENOPIA 14
474 BLOOD CHOLESTEROL INCREASED 14
475 DISABILITY 14
476 DRUG EFFECT INCOMPLETE 14
477 FACIAL PARESIS 14
478 GASTRIC DISORDER 14
479 GASTROINTESTINAL PAIN 14
480 GLOMERULAR FILTRATION RATE DECREASED 14
481 HAND DEFORMITY 14
482 HEPATIC STEATOSIS 14
483 HIP ARTHROPLASTY 14
484 IMPAIRED HEALING 14
485 INJECTION SITE RASH 14
486 LYMPHOCYTE COUNT DECREASED 14
487 LYMPHOPENIA 14
488 MOTOR DYSFUNCTION 14
489 MUSCLE DISORDER 14
490 MUSCLE TIGHTNESS 14
491 NERVOUS SYSTEM DISORDER 14
492 ORAL CANDIDIASIS 14
493 OSTEOMYELITIS 14
494 PALLOR 14
495 POISONING DELIBERATE 14
496 POST PROCEDURAL COMPLICATION 14
497 RASH ERYTHEMATOUS 14
498 SKIN DISCOLOURATION 14
499 SKIN DISORDER 14
500 SKIN EXFOLIATION 14
501 SPINAL OSTEOARTHRITIS 14
502 THERAPEUTIC PRODUCT EFFECT DELAYED 14
503 THIRST 14
504 TOOTH DISORDER 14
505 UTERINE LEIOMYOMA 14
506 WHEELCHAIR USER 14
507 WITHDRAWAL SYNDROME 14
508 BACK DISORDER 13
509 BODY TEMPERATURE DECREASED 13
510 ENTERITIS 13
511 EOSINOPHILIA 13
512 EYE MOVEMENT DISORDER 13
513 FRACTURE 13
514 FREQUENT BOWEL MOVEMENTS 13
515 FRUSTRATION TOLERANCE DECREASED 13
516 HAEMOGLOBIN ABNORMAL 13
517 HEPATOTOXICITY 13
518 INABILITY TO AFFORD MEDICATION 13
519 INFUSION SITE SWELLING 13
520 LOWER LIMB FRACTURE 13
521 MENOPAUSE 13
522 MITRAL VALVE INCOMPETENCE 13
523 OCULAR DISCOMFORT 13
524 ORAL FUNGAL INFECTION 13
525 PHOTOSENSITIVITY REACTION 13
526 PLATELET COUNT INCREASED 13
527 RESPIRATORY SYNCYTIAL VIRUS INFECTION 13
528 STOMATITIS 13
529 TASTE DISORDER 13
530 TENDONITIS 13
531 TYPE 2 DIABETES MELLITUS 13
532 ABSCESS 12
533 AGEUSIA 12
534 BACTERAEMIA 12
535 BLISTER 12
536 BLOOD GLUCOSE DECREASED 12
537 BLOOD SODIUM DECREASED 12
538 CEREBRAL HAEMORRHAGE 12
539 CHROMATURIA 12
540 CONCUSSION 12
541 DEVICE DISLOCATION 12
542 ELECTROLYTE IMBALANCE 12
543 EYE SWELLING 12
544 FACIAL PARALYSIS 12
545 FEEDING DISORDER 12
546 HYPOTONIA 12
547 INFUSION SITE BRUISING 12
548 INTENTIONAL OVERDOSE 12
549 KIDNEY INFECTION 12
550 MELAENA 12
551 MYOSITIS 12
552 NOCTURIA 12
553 PHARYNGITIS 12
554 PRODUCT USE COMPLAINT 12
555 PSEUDOMONAS INFECTION 12
556 PULMONARY CONGESTION 12
557 RASH MACULO-PAPULAR 12
558 RENAL FAILURE ACUTE 12
559 RESTLESS LEGS SYNDROME 12
560 RESTLESSNESS 12
561 RETCHING 12
562 SINUS DISORDER 12
563 SUSPECTED COVID-19 12
564 THERAPEUTIC PRODUCT EFFECT VARIABLE 12
565 TINNITUS 12
566 TOXIC EPIDERMAL NECROLYSIS 12
567 VEIN DISORDER 12
568 WOUND INFECTION 12
569 ABASIA 11
570 ADIPOSIS DOLOROSA 11
571 ANOSMIA 11
572 ATRIOVENTRICULAR BLOCK COMPLETE 11
573 BLOOD ALKALINE PHOSPHATASE INCREASED 11
574 BLOOD BILIRUBIN INCREASED 11
575 BOWEL MOVEMENT IRREGULARITY 11
576 CARDIOMEGALY 11
577 CHOLECYSTECTOMY 11
578 CHRONIC KIDNEY DISEASE 11
579 COMPLICATION ASSOCIATED WITH DEVICE 11
580 COMPRESSION FRACTURE 11
581 CYANOSIS 11
582 DIAPHRAGMATIC PARALYSIS 11
583 DYSPNOEA AT REST 11
584 ENCEPHALOPATHY 11
585 EPILEPSY 11
586 EXTRA DOSE ADMINISTERED 11
587 GENERALISED OEDEMA 11
588 HAEMATOLOGICAL INFECTION 11
589 HEAD DISCOMFORT 11
590 HEMIPLEGIA 11
591 HORDEOLUM 11
592 HYPOGAMMAGLOBULINAEMIA 11
593 HYPOKINESIA 11
594 INFUSION SITE PRURITUS 11
595 INJECTION SITE URTICARIA 11
596 INTERNATIONAL NORMALISED RATIO INCREASED 11
597 INTERSTITIAL LUNG DISEASE 11
598 INTESTINAL TRANSIT TIME DECREASED 11
599 LOW DENSITY LIPOPROTEIN INCREASED 11
600 LUNG NEOPLASM MALIGNANT 11
601 MALIGNANT NEOPLASM PROGRESSION 11
602 MAST CELL ACTIVATION SYNDROME 11
603 MENTAL DISORDER 11
604 MIOSIS 11
605 MOOD ALTERED 11
606 MULTIPLE ALLERGIES 11
607 MYOCARDIAL NECROSIS MARKER INCREASED 11
608 NEUTROPHIL COUNT DECREASED 11
609 NIGHTMARE 11
610 OPHTHALMIC HERPES ZOSTER 11
611 PARANASAL SINUS DISCOMFORT 11
612 PELVIC FRACTURE 11
613 PRODUCT COLOUR ISSUE 11
614 RASH MACULAR 11
615 RENAL CYST 11
616 RESPIRATORY ACIDOSIS 11
617 RHINITIS 11
618 RIGHT VENTRICULAR FAILURE 11
619 SINUS CONGESTION 11
620 SPINAL FRACTURE 11
621 TACHYPNOEA 11
622 TOOTH INFECTION 11
623 TRANSAMINASES INCREASED 11
624 VAGINAL HAEMORRHAGE 11
625 WEIGHT FLUCTUATION 11
626 AFFECT LABILITY 10
627 ANGIOEDEMA 10
628 ANKLE FRACTURE 10
629 ARTHROPOD BITE 10
630 B-CELL LYMPHOMA RECURRENT 10
631 BLINDNESS TRANSIENT 10
632 BLOOD IMMUNOGLOBULIN G DECREASED 10
633 BLOOD PRESSURE DIASTOLIC ABNORMAL 10
634 BREAST CANCER 10
635 CARDIAC PACEMAKER INSERTION 10
636 CENTRAL VENOUS CATHETERISATION 10
637 CEREBRAL INFARCTION 10
638 COLITIS 10
639 COVID-19 PNEUMONIA 10
640 ENDOTRACHEAL INTUBATION 10
641 EYE CONTUSION 10
642 EYE INFECTION 10
643 FOETAL EXPOSURE DURING PREGNANCY 10
644 HAEMORRHAGE INTRACRANIAL 10
645 HEMIPARESIS 10
646 HEPATIC FAILURE 10
647 HEPATIC FUNCTION ABNORMAL 10
648 HUNGER 10
649 IMMUNE SYSTEM DISORDER 10
650 INCORRECT DRUG ADMINISTRATION RATE 10
651 INCORRECT PRODUCT ADMINISTRATION DURATION 10
652 INCREASED APPETITE 10
653 INJECTION SITE MASS 10
654 INTERVERTEBRAL DISC DEGENERATION 10
655 JAUNDICE 10
656 JOINT INJURY 10
657 LABORATORY TEST ABNORMAL 10
658 LIPASE INCREASED 10
659 MENTAL IMPAIRMENT 10
660 MENTAL STATUS CHANGES 10
661 MORPHOEA 10
662 NERVE COMPRESSION 10
663 NEUROMYOPATHY 10
664 OCULAR HYPERAEMIA 10
665 ORAL PAIN 10
666 PARANOIA 10
667 PNEUMOTHORAX 10
668 POLYNEUROPATHY 10
669 PRODUCT PRESCRIBING ISSUE 10
670 PRODUCT STORAGE ERROR 10
671 PROSTATE CANCER 10
672 PULMONARY FIBROSIS 10
673 PULMONARY OEDEMA 10
674 RED BLOOD CELL SEDIMENTATION RATE INCREASED 10
675 SARS-COV-2 TEST POSITIVE 10
676 SCAR 10
677 SJOGREN^S SYNDROME 10
678 SKIN BURNING SENSATION 10
679 SPINAL OPERATION 10
680 SPINAL STENOSIS 10
681 SUDDEN DEATH 10
682 THERAPEUTIC PRODUCT INEFFECTIVE 10
683 TOOTHACHE 10
684 ACNE 9
685 BASAL CELL CARCINOMA 9
686 BEDRIDDEN 9
687 BLOOD IMMUNOGLOBULIN G INCREASED 9
688 BLOOD POTASSIUM INCREASED 9
689 BRAIN ABSCESS 9
690 CLOSTRIDIUM DIFFICILE COLITIS 9
691 CLUMSINESS 9
692 CORONAVIRUS INFECTION 9
693 DECUBITUS ULCER 9
694 DEVICE OCCLUSION 9
695 DEVICE RELATED INFECTION 9
696 ESCHERICHIA INFECTION 9
697 EYELID DISORDER 9
698 FOOD ALLERGY 9
699 HAEMATEMESIS 9
700 INCOHERENT 9
701 INCREASED BRONCHIAL SECRETION 9
702 INITIAL INSOMNIA 9
703 INJECTION SITE INDURATION 9
704 JOINT DISLOCATION 9
705 MASS 9
706 MECHANICAL VENTILATION 9
707 MYOCARDITIS 9
708 MYOPATHY 9
709 OESOPHAGEAL CANDIDIASIS 9
710 ON AND OFF PHENOMENON 9
711 PAIN IN JAW 9
712 PERICARDIAL EFFUSION 9
713 PETECHIAE 9
714 PRODUCT SOLUBILITY ABNORMAL 9
715 PRODUCT TASTE ABNORMAL 9
716 PYELONEPHRITIS 9
717 RASH GENERALISED 9
718 RASH MORBILLIFORM 9
719 RESPIRATORY RATE INCREASED 9
720 RESTRICTIVE PULMONARY DISEASE 9
721 SPINAL COMPRESSION FRACTURE 9
722 SUICIDE ATTEMPT 9
723 THYMECTOMY 9
724 TONGUE DISORDER 9
725 TOOTH ABSCESS 9
726 ULCER HAEMORRHAGE 9
727 UPPER GASTROINTESTINAL HAEMORRHAGE 9
728 VITAMIN B12 DEFICIENCY 9
729 ABDOMINAL PAIN LOWER 8
730 ABNORMAL BEHAVIOUR 8
731 ACCIDENTAL OVERDOSE 8
732 ADRENAL INSUFFICIENCY 8
733 ALTERED STATE OF CONSCIOUSNESS 8
734 ARTERIOSCLEROSIS 8
735 ARTERIOSPASM CORONARY 8
736 ATAXIA 8
737 BLADDER DISORDER 8
738 BLOOD CALCIUM DECREASED 8
739 BLOOD CALCIUM INCREASED 8
740 BRADYKINESIA 8
741 CARDIOMYOPATHY 8
742 CIRCULATORY COLLAPSE 8
743 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8
744 DEMENTIA ALZHEIMER^S TYPE 8
745 DEVICE DIFFICULT TO USE 8
746 DEVICE MALFUNCTION 8
747 DIVERTICULUM 8
748 EJECTION FRACTION DECREASED 8
749 ENDOCARDITIS 8
750 FEBRILE BONE MARROW APLASIA 8
751 FLUID OVERLOAD 8
752 GASTROINTESTINAL TUBE INSERTION 8
753 GLOSSODYNIA 8
754 GLUCOSE TOLERANCE IMPAIRED 8
755 HAEMOLYTIC ANAEMIA 8
756 HYPERVOLAEMIA 8
757 ILEUS 8
758 IMPAIRED DRIVING ABILITY 8
759 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 8
760 INCREASED TENDENCY TO BRUISE 8
761 JOINT RANGE OF MOTION DECREASED 8
762 LEFT VENTRICULAR HYPERTROPHY 8
763 LIGAMENT SPRAIN 8
764 LUMBAR SPINAL STENOSIS 8
765 LYMPHOCYTE COUNT INCREASED 8
766 MALNUTRITION 8
767 MENINGIOMA 8
768 METABOLIC ACIDOSIS 8
769 MULTIPLE ORGAN DYSFUNCTION SYNDROME 8
770 MULTIPLE SCLEROSIS 8
771 NERVE INJURY 8
772 ONYCHOMYCOSIS 8
773 PANCREATITIS ACUTE 8
774 PERIPHERAL SENSORY NEUROPATHY 8
775 POOR QUALITY PRODUCT ADMINISTERED 8
776 POST PROCEDURAL INFECTION 8
777 POTENTIATING DRUG INTERACTION 8
778 PREGNANCY 8
779 PRURITUS GENERALISED 8
780 PSORIATIC ARTHROPATHY 8
781 RESPIRATORY ALKALOSIS 8
782 RESPIRATORY DEPRESSION 8
783 RETINAL DETACHMENT 8
784 RHINOVIRUS INFECTION 8
785 SKIN REACTION 8
786 SLUGGISHNESS 8
787 SOLAR LENTIGO 8
788 STENT PLACEMENT 8
789 THYROID CANCER 8
790 TOXIC SKIN ERUPTION 8
791 ULCER 8
792 UPPER-AIRWAY COUGH SYNDROME 8
793 VASCULAR DEVICE INFECTION 8
794 ABDOMINAL ABSCESS 7
795 ABORTION INDUCED 7
796 ACCIDENTAL EXPOSURE TO PRODUCT 7
797 ACUTE CORONARY SYNDROME 7
798 ACUTE RESPIRATORY DISTRESS SYNDROME 7
799 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 7
800 ANAPHYLACTIC SHOCK 7
801 ANTIACETYLCHOLINE RECEPTOR ANTIBODY POSITIVE 7
802 ARTERIOSCLEROSIS CORONARY ARTERY 7
803 ASPHYXIA 7
804 ATRIOVENTRICULAR BLOCK 7
805 AUTONOMIC NERVOUS SYSTEM IMBALANCE 7
806 AVERSION 7
807 BLOOD PRESSURE SYSTOLIC ABNORMAL 7
808 BLOOD TEST ABNORMAL 7
809 BODY TEMPERATURE INCREASED 7
810 BONE CONTUSION 7
811 BRAIN OEDEMA 7
812 BRONCHIECTASIS 7
813 CEREBRAL ATROPHY 7
814 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 7
815 COLON CANCER 7
816 COORDINATION ABNORMAL 7
817 CRYING 7
818 DEAFNESS 7
819 DEVICE BREAKAGE 7
820 DEVICE INFUSION ISSUE 7
821 DIABETES MELLITUS INADEQUATE CONTROL 7
822 DRUG-INDUCED LIVER INJURY 7
823 EAR PRURITUS 7
824 EHLERS-DANLOS SYNDROME 7
825 ERECTILE DYSFUNCTION 7
826 FLANK PAIN 7
827 FUNGAL SKIN INFECTION 7
828 GASTROINTESTINAL INFECTION 7
829 GASTROINTESTINAL SOUNDS ABNORMAL 7
830 GRIP STRENGTH DECREASED 7
831 HAEMOGLOBIN INCREASED 7
832 HAEMOPTYSIS 7
833 HAND FRACTURE 7
834 HEPATITIS 7
835 HEPATOCELLULAR INJURY 7
836 HIATUS HERNIA 7
837 HOSPICE CARE 7
838 HUMERUS FRACTURE 7
839 HYPERCAPNIA 7
840 HYPERKERATOSIS 7
841 HYPOMAGNESAEMIA 7
842 HYPOPNOEA 7
843 HYSTERECTOMY 7
844 IMPAIRED WORK ABILITY 7
845 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 7
846 INFUSION SITE IRRITATION 7
847 INFUSION SITE URTICARIA 7
848 INJECTION SITE IRRITATION 7
849 MALIGNANT MELANOMA 7
850 METASTASES TO LIVER 7
851 MUSCLE DISCOMFORT 7
852 NECROTISING MYOSITIS 7
853 OPTIC NEUROPATHY 7
854 OROPHARYNGEAL DISCOMFORT 7
855 ORTHOPNOEA 7
856 OSTEOPENIA 7
857 PANCREATIC DISORDER 7
858 PANCREATIC ENZYMES INCREASED 7
859 PARESIS 7
860 PELVIC PAIN 7
861 PRINZMETAL ANGINA 7
862 PSYCHOMOTOR HYPERACTIVITY 7
863 QUALITY OF LIFE DECREASED 7
864 RESPIRATION ABNORMAL 7
865 RHABDOMYOLYSIS 7
866 SENSORY LOSS 7
867 SINUS TACHYCARDIA 7
868 SKIN CANCER 7
869 SMALL INTESTINAL OBSTRUCTION 7
870 SWELLING OF EYELID 7
871 THYROID DISORDER 7
872 TOOTH EXTRACTION 7
873 TOOTH FRACTURE 7
874 VERTEBRAL FORAMINAL STENOSIS 7
875 ABDOMINAL TENDERNESS 6
876 ADVERSE REACTION 6
877 ALLERGY TO CHEMICALS 6
878 ANGIOPATHY 6
879 APLASIA 6
880 APLASIA PURE RED CELL 6
881 ARTHRITIS BACTERIAL 6
882 BLOOD CHLORIDE INCREASED 6
883 BLOOD MAGNESIUM DECREASED 6
884 BLOOD TESTOSTERONE DECREASED 6
885 BONE MARROW FAILURE 6
886 CANDIDA INFECTION 6
887 CARBON DIOXIDE INCREASED 6
888 CATHETER SITE PAIN 6
889 CHOLECYSTITIS ACUTE 6
890 CHOLECYSTITIS INFECTIVE 6
891 CHRONIC SINUSITIS 6
892 CYTOMEGALOVIRUS INFECTION 6
893 DERMATITIS EXFOLIATIVE 6
894 DEVICE USE ERROR 6
895 DIABETIC NEUROPATHY 6
896 DIAPHRAGMATIC DISORDER 6
897 DRUG DISPENSING ERROR 6
898 DRUG DOSE OMISSION BY DEVICE 6
899 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6
900 DRY THROAT 6
901 DYSPHEMIA 6
902 ELECTRIC SHOCK SENSATION 6
903 ELECTROCARDIOGRAM ABNORMAL 6
904 ELECTROCARDIOGRAM T WAVE INVERSION 6
905 ENURESIS 6
906 ERYTHEMA OF EYELID 6
907 EUGLYCAEMIC DIABETIC KETOACIDOSIS 6
908 EXOSTOSIS 6
909 EXPIRED PRODUCT ADMINISTERED 6
910 FAECAL VOMITING 6
911 FEELING DRUNK 6
912 GASTROINTESTINAL STOMA COMPLICATION 6
913 GINGIVAL BLEEDING 6
914 GRAVES^ DISEASE 6
915 HAEMOLYSIS 6
916 HAIR GROWTH ABNORMAL 6
917 HYPERLIPIDAEMIA 6
918 HYPERTHYROIDISM 6
919 HYPERTONIC BLADDER 6
920 HYPOTHERMIA 6
921 INTESTINAL PERFORATION 6
922 INTRAOCULAR PRESSURE INCREASED 6
923 IRON DEFICIENCY ANAEMIA 6
924 IRRITABLE BOWEL SYNDROME 6
925 JAW DISORDER 6
926 LIVER FUNCTION TEST INCREASED 6
927 LYME DISEASE 6
928 LYMPHOEDEMA 6
929 MACULAR DEGENERATION 6
930 MEAN CELL VOLUME INCREASED 6
931 MIDDLE INSOMNIA 6
932 MORVAN SYNDROME 6
933 MULTI-ORGAN FAILURE 6
934 MUSCLE SPASTICITY 6
935 NEOPLASM RECURRENCE 6
936 NEUROGENIC BLADDER 6
937 NO THERAPEUTIC RESPONSE 6
938 OBESITY 6
939 OESOPHAGITIS 6
940 ORAL DISCOMFORT 6
941 OSTEONECROSIS 6
942 PAIN OF SKIN 6
943 PERSONALITY DISORDER 6
944 PHARYNGITIS STREPTOCOCCAL 6
945 PHYSICAL DECONDITIONING 6
946 PNEUMONIA BACTERIAL 6
947 PNEUMONIA PSEUDOMONAL 6
948 POLYURIA 6
949 POST PROCEDURAL HAEMORRHAGE 6
950 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 6
951 PROSTATIC DISORDER 6
952 PULMONARY ARTERIAL HYPERTENSION 6
953 PULMONARY HYPERTENSION 6
954 REHABILITATION THERAPY 6
955 ROTATOR CUFF SYNDROME 6
956 SARS-COV-2 TEST NEGATIVE 6
957 SCAB 6
958 SCREAMING 6
959 SENSITIVE SKIN 6
960 SERRATIA INFECTION 6
961 SERUM FERRITIN INCREASED 6
962 SNEEZING 6
963 SPONDYLITIS 6
964 STOMA SITE DISCHARGE 6
965 STRESS CARDIOMYOPATHY 6
966 SYNOVITIS 6
967 SYSTEMIC SCLERODERMA 6
968 TONGUE MOVEMENT DISTURBANCE 6
969 TRISMUS 6
970 TUBULOINTERSTITIAL NEPHRITIS 6
971 URINARY TRACT DISORDER 6
972 UVEITIS 6
973 VARICOSE VEIN 6
974 VENTRICULAR EXTRASYSTOLES 6
975 VISUAL ACUITY REDUCED 6
976 VITREOUS FLOATERS 6
977 ACCIDENT 5
978 AMYLASE INCREASED 5
979 ANIMAL BITE 5
980 APLASTIC ANAEMIA 5
981 APPENDICECTOMY 5
982 APPLICATION SITE PAIN 5
983 ARTERIAL OCCLUSIVE DISEASE 5
984 ARTHRITIS INFECTIVE 5
985 AUTONOMIC NEUROPATHY 5
986 BLOOD COUNT ABNORMAL 5
987 BLOOD CREATININE DECREASED 5
988 BLOOD GLUCOSE FLUCTUATION 5
989 BLOOD THYROID STIMULATING HORMONE DECREASED 5
990 BRONCHOSPASM 5
991 CANDIDIASIS 5
992 CARPAL TUNNEL SYNDROME 5
993 CATARACT OPERATION 5
994 CHOLESTASIS 5
995 COAGULOPATHY 5
996 CONGENITAL MYASTHENIC SYNDROME 5
997 CONSCIOUSNESS FLUCTUATING 5
998 CROHN^S DISEASE 5
999 CYANOPSIA 5